Print Page  Close Window

10-K
ICONIX BRAND GROUP, INC. filed this Form 10-K on 03/28/2019
Entire Document
 << Previous Page | Next Page >>

 

Proceeds from sale of interest in Badgley Mischka in certain international joint

   ventures

 

 

2,500

 

 

 

 

Proceeds from note receivable from formation of Buffalo joint venture

 

 

1,409

 

 

 

 

Proceeds from sale of Sharper Image

 

 

1,755

 

 

 

 

Proceeds from sale of interest in Badgley Mischka Canada

 

 

 

 

 

375

 

Proceeds from sale of interest in Sharper Image Canada

 

 

 

 

 

500

 

Proceeds from sale of Galore Media

 

 

 

 

 

500

 

Proceeds from sale of NGX

 

 

 

 

 

2,561

 

Proceeds from sale of interest in Complex Media

 

 

958

 

 

 

2,728

 

Proceeds from sale of discontinued operation, net of cash sold

 

 

 

 

 

336,675

 

Proceeds from sale of trademarks and related notes receivable

 

 

 

 

 

1,922

 

Decrease in cash and cash equivalents from deconsolidation of joint

   venture

 

 

 

 

 

(1,853

)

Additions to trademarks

 

 

(339

)

 

 

(212

)

Net cash provided by (used in) continuing investing activities

 

 

(5,657

)

 

 

330,599

 

Net cash used in discontinued investing activities

 

 

 

 

 

(84

)

Net cash provided by (used in) investing activities

 

 

(5,657

)

 

 

330,515

 

Cash flows (used in) provided by financing activities:

 

 

 

 

 

 

 

 

Proceeds from Variable Funding Notes

 

 

 

 

 

73,437

 

Proceeds from long-term debt, net of discount and fees

 

 

95,700

 

 

 

307,030

 

Proceeds from sale of trademarks and related notes receivables to

   consolidated joint ventures

 

 

195

 

 

 

6,942

 

Payment of long-term debt

 

 

(157,292

)

 

 

(824,867

)

Repurchase of convertible notes

 

 

 

 

 

(58,810

)

Payment of make-whole premium on repayment of long-term debt

 

 

 

 

 

(13,933

)

Prepaid financing costs

 

 

(5,423

)

 

 

(7,145

)

Distributions to non-controlling interests

 

 

(14,902

)

 

 

(5,191

)

Excess tax benefit from share-based payment arrangements

 

 

 

 

 

 

Tax benefit related to amortization of convertible notes' discount

 

 

159

 

 

 

78

 

Cost of shares repurchased on vesting of restricted stock and exercise of

   stock options

 

 

(223

)

 

 

(1,078

)

Net cash used in continuing financing activities

 

 

(81,786

)

 

 

(523,537

)

Net cash used in discontinued financing activities

 

 

 

 

 

(23,873

)

Net cash used in financing activities

 

 

(81,786

)

 

 

(547,410

)

Effect of exchange rate changes on cash

 

 

(697

)

 

 

2,834

 

Net decrease in cash, cash equivalents, and restricted cash

 

 

(32,058

)

 

 

(211,987

)

Cash, cash equivalents and restricted cash from continuing operations, beginning of period

 

 

114,693

 

 

 

314,383

 

Cash and cash equivalents from discontinued operations, beginning of period

 

 

 

 

 

12,297

 

Cash, cash equivalents, and restricted cash, beginning of period

 

 

114,693

 

 

 

326,680

 

Cash, cash equivalents, and restricted cash, end of period

 

 

82,635

 

 

 

114,693

 

Less: Cash and cash equivalents from discontinued operations,

   end of period

 

 

 

 

 

 

Cash, cash equivalents, and restricted cash of continuing operations, end of period

 

$

82,635

 

 

$

114,693

 

65


 << Previous Page | Next Page >>